Mutagenic Tests Confirm That New Acetylacetonate Pt(II) Complexes Induce Apoptosis in Cancer Cells Interacting with Nongenomic Biological Targets

<table>Mutagenicities of <b>1a</b>, <b>2a</b>, <b>2b</b> complexes and <i>cisplatin</i> on TA98 and TA100 <i>Salmonella typhimurium</i> strains.</table>

Metal-Based Drugs

fig3

Figure 3

Figure 3: Mutagenic Tests Confirm That New Acetylacetonate Pt(II) Complexes Induce Apoptosis in Cancer Cells Interacting with Nongenomic Biological Targets 

Figure 3 | Mutagenic Tests Confirm That New Acetylacetonate Pt(II) Complexes Induce Apoptosis in Cancer Cells Interacting with Nongenomic Biological Targets 